デフォルト表紙
市場調査レポート
商品コード
1058818

乳房病変局所化の世界市場(2021年~2028年)

Global Breast Lesion Localization Market - 2021-2028

出版日: | 発行: DataM Intelligence | ページ情報: 英文 185 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
乳房病変局所化の世界市場(2021年~2028年)
出版日: 2022年02月16日
発行: DataM Intelligence
ページ情報: 英文 185 Pages
納期: 約2営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の乳房病変局所化市場について調査分析し、市場力学、業界分析、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 世界の乳房病変局所化市場の調査手法と範囲

  • 調査手法
  • 調査の目的と調査範囲

第2章 世界の乳房病変局所化市場-市場の定義と概要

第3章 世界の乳房病変局所化市場-エグゼクティブサマリー

  • 市場の内訳:タイプ別
  • 市場の内訳:生検技術別
  • 市場の内訳:エンドユーザー別
  • 市場の内訳:地域別

第4章 世界の乳房病変局所化市場-市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界の乳房病変局所化市場-業界分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • アンメットニーズ

第6章 世界の乳房病変局所化市場-COVID-19分析

  • 市場でのCOVID-19の分析
    • COVID-19以前の市場シナリオ
    • 現在のCOVID-19の市場シナリオ
    • COVID-19以後の市場シナリオ/将来の市場シナリオ
  • COVID-19における価格の力学
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界の乳房病変局所化市場-タイプ別

  • イントロダクション
  • 市場規模分析、および前年比成長分析(%):タイプ別
  • 市場魅力指数:タイプ別
    • ワイヤー局在化*
    • 放射性同位元素の局在化
    • 放射性シードの局在化
    • ラジオオカルト病変の局在化
    • その他

第8章 世界の乳房病変局所化市場:生検技術別

  • イントロダクション
  • 市場規模分析、および前年比成長分析(%):生検技術別
  • 市場魅力指数:生検技術別
    • 穿刺吸引生検
    • コア針生検
    • 外科的生検
    • その他

第9章 世界の乳房病変局所化市場:エンドユーザー別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):エンドユーザー別
    • 市場魅力指数:エンドユーザー別
  • 病院および診療所*
    • イントロダクション
    • 市場規模分析(100万米ドル)(2019年~2028年)、および前年比成長分析(%)(2020年~2028年)
  • 診断センター
  • 外来手術センター
  • その他

第10章 世界の乳房病変局所化市場:地域別

  • イントロダクション
    • 市場規模分析(100万米ドル)(2019年~2028年)、および前年比成長分析(%)(2020年~2028年):地域別
    • 市場魅力指数:地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東とアフリカ

第11章 世界の乳房病変局所化市場-競合情勢

  • 主な発展と戦略
  • 企業シェア分析
  • 製品のベンチマーク

第12章 世界の乳房病変局所化市場-企業プロファイル

  • Somatex Medical Technologies GmbH*
    • 企業概要
    • 製品ポートフォリオおよび説明
    • 主要ハイライト
    • 財務概要
  • Becton, Dickinson and Company
  • Merit Medical Systems
  • Endomagnetics Ltd
  • Ranfac Corp.
  • Kubtec X-Ray
  • Meditech Devices Pvt Ltd
  • Argon Medical
  • Vigeo srl
  • Mammotome

第13章 世界の乳房病変局所化市場-DataM

  • 付録
  • 当社・サービスについて
  • お問い合わせ
目次
Product Code: DMMD4685

Market Overview

The global breast lesion localization market size was valued at US$ XX million in 2020 and is estimated to reach US$ XX million by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Breast lesion localization is a common procedure that has evolved as surgical, imaging, and biomedical technology have advanced. Wire localization was the first technique introduced years ago to assist in the localization of nonpalpable, image-detected breast lesions.

Market Dynamics

The factors driving the global breast lesion localization market are technological advancements and increased public awareness of breast cancer diagnosis.

The technological advancements are expected to drive the market growth in the forecast period

Technological advancements can make localization easier, safer, and more accurate while improving care coordination and collaboration between radiologists and surgeons. Furthermore, they promise to spur further breast cancer detection and surgery innovation, such as streamlining sentinel lymph node procedures and allowing surgeons to improve cosmetic outcomes.

Instead of wires, some health care organizations are using newer implantable devices, such as radioactive seeds or other nonradioactive tags, to mark breast lesions. The most recent generation of fully implantable nonradioactive markers incorporates wireless radiofrequency identification (RFID) technology that can be detected by a handheld reader, which the FDA recently approved. These devices can establish a new standard of care for localization.

Furthermore, wire-guided localization (WL) is currently the most widely used method for locating non-palpable breast lesions. Preoperative image-guided localization of breast lesions is a common procedure that has evolved rapidly over the last few decades. Continuous technological advancements and the results of new clinical trials have provided increasing insight and new opportunities for breast specialists to choose from a variety of effective techniques.

The problems associated with breast lesion localization is expected to hamper the market growth

Patient discomfort, the potential need to perform localization on the day of surgery, creating logistical challenges that limit OR efficiency, wire migration and transection, the lack of a point source for reorientation during surgery, and a suboptimal cosmetic outcome are all limitations of WL (wire-guided localization). Wire-guided localization has a number of drawbacks. Because a portion of the wire is exposed, it has the potential to dislodge, migrate, kink, fracture, or be transected prior to or during surgery. Vasovagal reactions have been reported in 10-20% of patients. Furthermore, the radiologist's wire entry site may not correspond to the surgeon's preferred skin incision site. This jeopardises incision positioning, limiting the extent of surgical dissection and affecting cosmesis. Wire placement is typically performed on the day of surgery in the United States, limiting scheduling flexibility and OR efficiency.

COVID-19 Impact Analysis

The COVID-19 pandemic posed a unique set of challenges for clinicians in managing women who required periodic screening mammography, imaging, and/or needle biopsy for suspected breast cancer. Because of the combination of lockdown, the need for social distancing, and limited hospital resources, routine outpatient breast imaging activity has been drastically reduced in many cases. As a result, it is critical to determine which women require immediate or non-reschedulable care can wait for a reasonable amount of time or can wait until the pandemic is over. Because of the change in service delivery caused by the pandemic, the logistics of breast surgery theatre list planning became more complex, especially because of the need for radiologists and the assistance of radiographers to wire localize breast lesions. With staffing uncertainty due to redeployment and the possibility of staff being absent due to illness or self-isolation, lists with wire localizations could not be planned with any certainty. Furthermore, many National Health Service (NHS) trusts relocated their cancer surgery to a 'cold site,' remote from their main radiology departments, where localizations would take place.

Segment Analysis

Based on type, the wire localization segment is expected to dominate the market growth

Wire localization is a procedure performed prior to breast cancer surgery to determine the location of the abnormality (the wire marks the spot) so that the surgeon knows exactly what tissue to remove. This procedure is performed under the supervision of a mammogram or an ultrasound. Many impalpable breast lesions are being detected as mammography screening for breast cancer increases. These lesions should be definitively diagnosed using image-guided needle biopsy first. Breast biopsy with needle localization is thus used to diagnose impalpable breast lesions. Some of these lesions may require diagnostic or therapeutic surgical biopsy after needle biopsy. Surgical excision is recommended if a malignant or indefinite diagnosis is obtained. In turn, this necessitates precise localization of the lesion to ensure correct and adequate removal of the lesions while minimizing the degree of cosmetic disfigurement.

For non-palpable lesions, wire localization is performed prior to surgery. A wire is inserted, usually with the aid of ultrasound, with the needle's tip-in or near the lesion. If the lesion cannot be seen on ultrasound, the wire can be inserted using a stereotactic or off-hand technique. Following excision, the specimen is X-rayed to ensure that the lesion has been removed. There is little discomfort associated with this procedure, aside from a small puncture in the skin caused by the needle.

Geographical Analysis

North America region is expected to hold the largest market share in the global breast lesion localization market

The increasing prevalence of breast cancer is expected to drive market growth. Approximately more than 2.8 million women in the United States undergo breast procedures that necessitate precisely locating a tumor for a lumpectomy or biopsy each year. One in every eight women in the United States (13%) will develop invasive breast cancer throughout their lifetime. An estimated 287,850 new cases of invasive breast cancer will be diagnosed in women in the United States in 2022, along with 51,400 new non-invasive breast cancer cases. Preoperative wire needle localization (WL) and non-wire localization (NL) are accepted standard methods in the United States for guiding intraoperative surgical excision of nonpalpable breast lesions.

Hence, with the increasing incidence of breast cancer procedures, the breast lesion localization market is expected to grow in this region.

Competitive Landscape

The global breast lesion localization market is highly competitive with acquisitions, product launches, and collaborations. Some of the key players in the market are SOMATEX Medical Technologies GmbH, Becton, Dickinson and Company, Merit Medical Systems., Endomagnetics Ltd, Ranfac Corp., Kubtec X-Ray, Miltenyi Biotec GMBH, Meditech Devices Pvt Ltd, Argon Medical, Vigeo srl, Mammotome

Somatex Medical Technologies GmbH

Overview: SOMATEX manufactures high-quality single-use medical devices to aid in diagnosis and therapy. The company manufactures products in breast care, soft tissue and bone marrow biopsy, pulmonary interventions, foetal therapy, assisted reproduction, and radiation protection. The company was founded in 1992 and had headquarters in Berlin.

Product Portfolio: The company's Somatex localization wires are 20-gauge thin, sharp puncture cannulas, which ensures that treatment is as minimally invasive as possible. Localization wires are made of the biocompatible implant material Nitinol and come in various cannula lengths.

Why Purchase the Report?

Visualize the composition of the global breast lesion localization market segmentation by type, by biopsy technique, and end user highlighting the key commercial assets and players.

Identify commercial opportunities in global breast lesion localization market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global breast lesion localization market - level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global breast lesion localization market report would provide an access to an approx. 45+market data table, 40+figures and 180 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Breast Lesion Localization Market - By Type

Wire Localization

Radioisotope Localization

Radioactive Seed Localization

Radio Occult Lesion Localization

Other

Global Breast Lesion Localization Market - By Biopsy Technique

Fine Needle Aspiration Biopsy

Core Needle Biopsy

Surgical Biopsy

Other

Global Breast Lesion Localization Market - By End User

Hospitals and Clinics

Diagnostic Centres

Ambulatory Surgical Centres

Other

Global Breast Lesion Localization Market - By Region

North America

Europe

South America

Asia Pacific

Middle East and Africa

Table of Contents

1. Global Breast Lesion Localization Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Breast Lesion Localization Market - Market Definition and Overview

3. Global Breast Lesion Localization Market - Executive Summary

  • 3.1. Market Snippet By Type
  • 3.2. Market Snippet By Biopsy Technique
  • 3.3. Market Snippet By End User
  • 3.4. Market Snippet By Region

4. Global Breast Lesion Localization Market -Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. The problems associated with breast lesion localization
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Breast Lesion Localization Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs

6. Global Breast Lesion Localization Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Breast Lesion Localization Market - By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 7.3. Market Attractiveness Index, By Type
    • 7.3.1. Wire Localization*
      • 7.3.1.1.1. Introduction
      • 7.3.1.1.2. Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    • 7.3.2. Radioisotope Localization
    • 7.3.3. Radioactive Seed Localization
    • 7.3.4. Radio Occult Lesion Localization
    • 7.3.5. Other

8. Global Breast Lesion Localization Market - By Biopsy Technique

  • 8.3. Introduction
  • 8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Biopsy Technique
  • 8.5. Market Attractiveness Index, By Biopsy Technique
    • 8.5.2. Fine Needle Aspiration Biopsy
      • 8.5.2.1.1. Introduction
      • 8.5.2.1.2. Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    • 8.5.3. Core Needle Biopsy
    • 8.5.4. Surgical Biopsy
    • 8.5.5. Other

9. Global Breast Lesion Localization Market - By End User

  • 9.3. Introduction
    • 9.3.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.3.3. Market Attractiveness Index, By End User
  • 9.4. Hospitals and Clinics*
    • 9.4.2. Introduction
    • 9.4.3. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.5. Diagnostic Centres
  • 9.6. Ambulatory Surgical Centres
  • 9.7. Other

10. Global Breast Lesion Localization Market - By Region

  • 10.3. Introduction
    • 10.3.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.3.3. Market Attractiveness Index, By Region
  • 10.4. North America
    • 10.4.2. Introduction
    • 10.4.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Biopsy Technique
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. U.S.
      • 10.4.6.2. Canada
      • 10.4.6.3. Mexico
  • 10.5. Europe
    • 10.5.2. Introduction
    • 10.5.3. Key Region-Specific Dynamics
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Biopsy Technique
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. Germany
      • 10.5.7.2. U.K.
      • 10.5.7.3. France
      • 10.5.7.4. Italy
      • 10.5.7.5. Spain
      • 10.5.7.6. Rest of Europe
  • 10.6. South America
    • 10.6.2. Introduction
    • 10.6.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Biopsy Technique
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.6.6.1. Brazil
      • 10.6.6.2. Argentina
      • 10.6.6.3. Rest of South America
  • 10.7. Asia Pacific
    • 10.7.2. Introduction
    • 10.7.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Biopsy Technique
    • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.7.6.1. China
      • 10.7.6.2. India
      • 10.7.6.3. Japan
      • 10.7.6.4. Australia
      • 10.7.6.5. Rest of Asia Pacific
  • 10.8. Middle East and Africa
    • 10.8.2. Introduction
    • 10.8.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Biopsy Technique
    • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Breast Lesion Localization Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.3. Company Share Analysis
  • 11.4. Product Benchmarking

12. Global Breast Lesion Localization Market - Company Profiles

  • 12.1. Somatex Medical Technologies GmbH*
    • 12.3.2. Company Overview
    • 12.3.3. Product Portfolio and Description
    • 12.3.4. Key Highlights
    • 12.3.5. Financial Overview
  • 12.2. Becton, Dickinson and Company
  • 12.3. Merit Medical Systems
  • 12.4. Endomagnetics Ltd
  • 12.5. Ranfac Corp.
  • 12.6. Kubtec X-Ray
  • 12.7. Meditech Devices Pvt Ltd
  • 12.8. Argon Medical
  • 12.9. Vigeo srl
  • 12.10. Mammotome

LIST NOT EXHAUSTIVE

13. Global Breast Lesion Localization Market - DataM

  • 13.3. Appendix
  • 13.4. About Us and Services
  • 13.5. Contact Us